Treatment approaches for patients with TP53-mutated mantle cell lymphoma.
Lew TE, Minson A, Dickinson M, Handunnetti SM, Blombery P, Khot A, Anderson MA, Ritchie D, Tam CS, Seymour JF.
Lew TE, et al.
Lancet Haematol. 2023 Feb;10(2):e142-e154. doi: 10.1016/S2352-3026(22)00355-6.
Lancet Haematol. 2023.
PMID: 36725119
Review.
Mantle cell lymphoma is an uncommon subtype of lymphoma characterised by clinical and biological heterogeneity. ...The poor outcomes for patients with TP53-mutated mantle cell lymphoma receiving chemoimmunotherapy and second-line B …
Mantle cell lymphoma is an uncommon subtype of lymphoma characterised by clinical and biological heterogeneity. …